Tech Company Inital Public Offerings
Design Therapeutics IPO
Design Therapeutics, based in Carlsbad, debuted as a public company on 3/26/2021.
Transaction Overview
Company Name
Announced On
3/26/2021
Transaction Type
IPO
Amount
$240,000,000
Proceeds Purpose
Use of proceeds for the Design Therapeutics IPO are outlined in the company's S1 filing.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
6005 Hidden Valley Rd. 220
Carlsbad, CA 92011
USA
Carlsbad, CA 92011
USA
Phone
Undisclosed
Website
Email Address
Overview
Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders caused by nucleotide repeat expansions. The company's lead program is focused on the treatment of Friedreich's ataxia and discovery efforts are ongoing in other degenerative diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Pratik Shah
Chief Executive Officer
João Siffert
Chief Operating Officer
Sean Jeffries
Co-Founder
Aseem Ansari
Browse more venture capital transactions:
Prev: 3/26/2021: Notarize venture capital transaction
Next: 3/26/2021: Polly Mortgage venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. All VC database entries reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs